Andecaliximab
Andecaliximab is a recombinant IgG4 monoclonal antibody targeting matrix metalloproteinase 9 (MMP9) . Andecaliximab showed antifibrotic effects in a mouse model of idiopathic pulmonary fibrosis. Andecaliximab can be used to study gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF), as well as dengue virus.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
MMP | Virus Protease
CAS Number
1518996-49-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6454077-01 0.1 mL
AGPHD1 (Hydroxylysine Kinase, 5-hydroxy-L-lysine Kinase, Aminoglycoside phosphotransferase Domain-Containing Protein 1, HYKK, AGPHD1) (MaxLight 405)
Ask
View Details 
MBS6454077-02 5x 0.1 mL
AGPHD1 (Hydroxylysine Kinase, 5-hydroxy-L-lysine Kinase, Aminoglycoside phosphotransferase Domain-Containing Protein 1, HYKK, AGPHD1) (MaxLight 405)
Ask
View Details 
